FDA raps Bayer in ‘combo' product crackdown
In a move that has divided industry, the Food and Drug Administration (FDA) has told German pharma giant Bayer in no uncertain terms to cease making disease reduction claims about products that contain both pharmaceutical and nutraceutical ingredients.